Ropes & Gray advised AbbVie on the deal.AbbVie (NYSE: ABBV), and Umoja Biopharma (Umoja) Umoja Biopharma announced two exclusive option and license agreements to develop multiple in-situ generated…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
